These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 951835)

  • 21. Plasma protein aspartyl damage is increased in hemodialysis patients: studies on causes and consequences.
    Perna AF; Ingrosso D; Satta E; Lombardi C; Galletti P; D'Aniello A; De Santo NG
    J Am Soc Nephrol; 2004 Oct; 15(10):2747-54. PubMed ID: 15466280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.
    Reidenberg MM; Odar-Cederlöf I; von Bahr C; Borgå O; Sjöqvist F
    N Engl J Med; 1971 Jul; 285(5):264-7. PubMed ID: 4378402
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of renal failure on the kinetics of intravenous midazolam: an "in vitro" and "in vivo" study.
    Calvo R; Suárez E; Rodríguez-Sasiain JM; Martínez I
    Res Commun Chem Pathol Pharmacol; 1992 Dec; 78(3):311-20. PubMed ID: 1475530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible mechanisms for reduced plasma clearance of diflunisal in rat experimental renal failure.
    Lin JH; Ulm EH; Duggan DE
    J Pharmacol Exp Ther; 1986 Sep; 238(3):978-84. PubMed ID: 3746671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding.
    Verbeeck RK; De Schepper PJ
    Clin Pharmacol Ther; 1980 May; 27(5):628-35. PubMed ID: 7371361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of carbohydrate metabolism after hemodialysis and hemofiltration in uremic patients.
    Geronemus R; Bosch JP; Thornton J; Rayfield EJ
    Arch Intern Med; 1982 Apr; 142(4):707-10. PubMed ID: 7041844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
    Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
    J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trace metal protein binding in normal and dialyzed uremic serum.
    Gidden H; Holland FF; Klein E
    Trans Am Soc Artif Intern Organs; 1980; 26():133-8. PubMed ID: 7245470
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum calcium in dialyzed uremic patients.
    Danesh BJ; Walker CH; Mathers NP
    N Engl J Med; 1970 Jul; 283(3):155-6. PubMed ID: 5423156
    [No Abstract]   [Full Text] [Related]  

  • 31. Statistical and parametric analysis of beta-2-microglobulin removal from uremic patients in high flux hemodialysis.
    Lee CJ; Hsiong CH; Chang YL; Cheng CH; Lian JD
    ASAIO J; 1994; 40(1):62-6. PubMed ID: 8186494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valproate plasma protein binding in the uremic condition.
    Brewster D; Muir NC
    Clin Pharmacol Ther; 1980 Jan; 27(1):76-82. PubMed ID: 6985855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum calcium in dialyzed uremic patients.
    Hattner RS; Jacobs J; Bernstein DS
    N Engl J Med; 1970 Jul; 283(3):155. PubMed ID: 5423155
    [No Abstract]   [Full Text] [Related]  

  • 34. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
    Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
    Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The removal of protein-bound solutes by dialysis.
    Meyer TW
    J Ren Nutr; 2012 Jan; 22(1):203-6. PubMed ID: 22200443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced in vitro binding of tryptophan by plasma in uremia.
    de Torrente A; Glazer GB; Gulyassy P
    Kidney Int; 1974 Oct; 6(4):222-9. PubMed ID: 4427418
    [No Abstract]   [Full Text] [Related]  

  • 37. Uric acid: binding levels of urate ions in normal and uraemic plasma, and in human serum albumin.
    Farrell PC; Ward RA; Hone PW
    Biochem Pharmacol; 1975 Oct; 24(20):1885-7. PubMed ID: 1191338
    [No Abstract]   [Full Text] [Related]  

  • 38. Protein binding of diazepam and digitoxin in uremic and normal serum.
    Kober A; Sjöholm I; Borgå O; Odar-Cederlöf I
    Biochem Pharmacol; 1979 Apr; 28(7):1037-42. PubMed ID: 444260
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of protein binding inhibitor on cultivated lymphocytes in uremic patients].
    Sanaka T; Kawashima Y; Takahashi F; Takuma T; Ota K; Sugino N
    Nihon Jinzo Gakkai Shi; 1983 Aug; 25(8):1063-9. PubMed ID: 6668745
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma protein binding of thiopental in patients with impaired renal or hepatic function.
    Ghoneim MM; Pandya H
    Anesthesiology; 1975 May; 42(5):545-9. PubMed ID: 1130720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.